https://stock.noler.com/us/stock/zyla-life-sciences https://stock.noler.com/us/stock/zyla-life-sciences/accounts-payable https://stock.noler.com/us/stock/zyla-life-sciences/accounts-receivable https://stock.noler.com/us/stock/zyla-life-sciences/accrual-at-carrying-value https://stock.noler.com/us/stock/zyla-life-sciences/accrued-liabilities-current https://stock.noler.com/us/stock/zyla-life-sciences/accrued-marketing-costs-current https://stock.noler.com/us/stock/zyla-life-sciences/accrued-professional-fees-current https://stock.noler.com/us/stock/zyla-life-sciences/accrued-royalties-current https://stock.noler.com/us/stock/zyla-life-sciences/accumulated-depreciation https://stock.noler.com/us/stock/zyla-life-sciences/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/zyla-life-sciences/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/zyla-life-sciences/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/zyla-life-sciences/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/zyla-life-sciences/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/zyla-life-sciences/amortization-of-financing-costs https://stock.noler.com/us/stock/zyla-life-sciences/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/zyla-life-sciences/aoci https://stock.noler.com/us/stock/zyla-life-sciences/asset-impairment-charges https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-debt-securities https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-debt-unrealized-loss-position-less-than-12-months-number-of-positions https://stock.noler.com/us/stock/zyla-life-sciences/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-less-than-one-year https://stock.noler.com/us/stock/zyla-life-sciences/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/zyla-life-sciences/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/zyla-life-sciences/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/zyla-life-sciences/capital-expenditures https://stock.noler.com/us/stock/zyla-life-sciences/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/zyla-life-sciences/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/zyla-life-sciences/cash-and-equivalents https://stock.noler.com/us/stock/zyla-life-sciences/cash-and-restricted-cash https://stock.noler.com/us/stock/zyla-life-sciences/cash-flow-breakdown https://stock.noler.com/us/stock/zyla-life-sciences/cash-uninsured-amount https://stock.noler.com/us/stock/zyla-life-sciences/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/zyla-life-sciences/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/zyla-life-sciences/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/zyla-life-sciences/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zyla-life-sciences/common-stock-value https://stock.noler.com/us/stock/zyla-life-sciences/comprehensive-income https://stock.noler.com/us/stock/zyla-life-sciences/concentration-risk-percentage https://stock.noler.com/us/stock/zyla-life-sciences/contract-liability https://stock.noler.com/us/stock/zyla-life-sciences/contract-with-customer-asset-net https://stock.noler.com/us/stock/zyla-life-sciences/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/zyla-life-sciences/cost-of-goods-and-services-sold-amortization https://stock.noler.com/us/stock/zyla-life-sciences/cost-of-goods-sold-amortization https://stock.noler.com/us/stock/zyla-life-sciences/costs-and-expenses https://stock.noler.com/us/stock/zyla-life-sciences/cover-page-shares-outstanding https://stock.noler.com/us/stock/zyla-life-sciences/current-assets https://stock.noler.com/us/stock/zyla-life-sciences/current-income-tax-expense-benefit https://stock.noler.com/us/stock/zyla-life-sciences/current-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/current-portion-of-long-term-debt https://stock.noler.com/us/stock/zyla-life-sciences/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/zyla-life-sciences/debt-carrying-amount https://stock.noler.com/us/stock/zyla-life-sciences/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/zyla-life-sciences/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/zyla-life-sciences/debt-face-amount https://stock.noler.com/us/stock/zyla-life-sciences/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/zyla-life-sciences/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/zyla-life-sciences/debt-maturing-in-year-five https://stock.noler.com/us/stock/zyla-life-sciences/debt-maturing-in-year-four https://stock.noler.com/us/stock/zyla-life-sciences/debt-maturing-in-year-three https://stock.noler.com/us/stock/zyla-life-sciences/debt-maturing-in-year-two https://stock.noler.com/us/stock/zyla-life-sciences/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/zyla-life-sciences/debt-repaid https://stock.noler.com/us/stock/zyla-life-sciences/debt-unamortized-discount https://stock.noler.com/us/stock/zyla-life-sciences/deferred-finance-costs-net https://stock.noler.com/us/stock/zyla-life-sciences/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/zyla-life-sciences/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/zyla-life-sciences/deferred-income-tax-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/zyla-life-sciences/deferred-revenue https://stock.noler.com/us/stock/zyla-life-sciences/deferred-revenue-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-gross https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-inventory https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-other https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-unrealized-currency-losses https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-liabilities-financing-arrangements https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-liabilities-gross-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/zyla-life-sciences/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/zyla-life-sciences/depreciation https://stock.noler.com/us/stock/zyla-life-sciences/depreciation-and-amortization-expense https://stock.noler.com/us/stock/zyla-life-sciences/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/discontinued-operation-provision-for-loss-gain-on-disposal-before-income-tax https://stock.noler.com/us/stock/zyla-life-sciences/due-from-related-parties-current https://stock.noler.com/us/stock/zyla-life-sciences/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/zyla-life-sciences/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/zyla-life-sciences/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/zyla-life-sciences/effective-tax-rate https://stock.noler.com/us/stock/zyla-life-sciences/employee-related-liabilities-current https://stock.noler.com/us/stock/zyla-life-sciences/eps https://stock.noler.com/us/stock/zyla-life-sciences/eps-basic https://stock.noler.com/us/stock/zyla-life-sciences/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/zyla-life-sciences/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/zyla-life-sciences/financing-cash-flow https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/zyla-life-sciences/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/zyla-life-sciences/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/zyla-life-sciences/foreign-pretax-income https://stock.noler.com/us/stock/zyla-life-sciences/form-d-other https://stock.noler.com/us/stock/zyla-life-sciences/fresh-start-adjustment-increase-decrease-cash-and-cash-equivalents https://stock.noler.com/us/stock/zyla-life-sciences/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/zyla-life-sciences/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/zyla-life-sciences/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/zyla-life-sciences/general-and-administrative-expense https://stock.noler.com/us/stock/zyla-life-sciences/goodwill https://stock.noler.com/us/stock/zyla-life-sciences/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/zyla-life-sciences/goodwill-impairment-loss https://stock.noler.com/us/stock/zyla-life-sciences/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/zyla-life-sciences/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/zyla-life-sciences/impairment-of-investments https://stock.noler.com/us/stock/zyla-life-sciences/income-tax https://stock.noler.com/us/stock/zyla-life-sciences/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-inventories https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/zyla-life-sciences/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/zyla-life-sciences/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/zyla-life-sciences/insider-transactions-corporate-securities https://stock.noler.com/us/stock/zyla-life-sciences/insider-transactions-other https://stock.noler.com/us/stock/zyla-life-sciences/insider-transactions-preferred https://stock.noler.com/us/stock/zyla-life-sciences/insider-transactions-stock-options https://stock.noler.com/us/stock/zyla-life-sciences/insider-transactions-stock-units https://stock.noler.com/us/stock/zyla-life-sciences/insider-transactions-warrants https://stock.noler.com/us/stock/zyla-life-sciences/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/zyla-life-sciences/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/zyla-life-sciences/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/zyla-life-sciences/interest-and-dividend-income-operating https://stock.noler.com/us/stock/zyla-life-sciences/interest-expense https://stock.noler.com/us/stock/zyla-life-sciences/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/zyla-life-sciences/interest-paid https://stock.noler.com/us/stock/zyla-life-sciences/interest-payable-current https://stock.noler.com/us/stock/zyla-life-sciences/inventory https://stock.noler.com/us/stock/zyla-life-sciences/inventory-finished-goods https://stock.noler.com/us/stock/zyla-life-sciences/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/zyla-life-sciences/inventory-work-in-process https://stock.noler.com/us/stock/zyla-life-sciences/investing-cash-flow https://stock.noler.com/us/stock/zyla-life-sciences/investment-income-amortization-of-discount https://stock.noler.com/us/stock/zyla-life-sciences/investment-income-amortization-of-premium https://stock.noler.com/us/stock/zyla-life-sciences/investment-income-interest https://stock.noler.com/us/stock/zyla-life-sciences/legal-fees https://stock.noler.com/us/stock/zyla-life-sciences/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/zyla-life-sciences/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/zyla-life-sciences/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/zyla-life-sciences/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/zyla-life-sciences/liabilities-subject-to-compromise https://stock.noler.com/us/stock/zyla-life-sciences/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/zyla-life-sciences/long-term-debt https://stock.noler.com/us/stock/zyla-life-sciences/long-term-line-of-credit https://stock.noler.com/us/stock/zyla-life-sciences/long-term-notes-and-loans https://stock.noler.com/us/stock/zyla-life-sciences/marketable-securities https://stock.noler.com/us/stock/zyla-life-sciences/marketable-securities-current https://stock.noler.com/us/stock/zyla-life-sciences/marketable-securities-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/net-cash-from https://stock.noler.com/us/stock/zyla-life-sciences/net-cash-from-financing-activities https://stock.noler.com/us/stock/zyla-life-sciences/net-cash-from-investing-activities https://stock.noler.com/us/stock/zyla-life-sciences/net-cash-from-operating-activities https://stock.noler.com/us/stock/zyla-life-sciences/net-change-in-cash https://stock.noler.com/us/stock/zyla-life-sciences/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/zyla-life-sciences/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/zyla-life-sciences/number-of-reportable-segments https://stock.noler.com/us/stock/zyla-life-sciences/number-of-reporting-units https://stock.noler.com/us/stock/zyla-life-sciences/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/zyla-life-sciences/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/zyla-life-sciences/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/zyla-life-sciences/operating-cash-flow https://stock.noler.com/us/stock/zyla-life-sciences/operating-expenses https://stock.noler.com/us/stock/zyla-life-sciences/operating-income https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-assets https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-cost https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-expense https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-liability https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-liability-current https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-2 https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-current https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/zyla-life-sciences/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/zyla-life-sciences/operating-leases-rent-expense-net https://stock.noler.com/us/stock/zyla-life-sciences/other-accrued-liabilities-current https://stock.noler.com/us/stock/zyla-life-sciences/other-current-assets https://stock.noler.com/us/stock/zyla-life-sciences/other-current-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/other-income https://stock.noler.com/us/stock/zyla-life-sciences/other-noncurrent-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/other-nonoperating-gains-losses https://stock.noler.com/us/stock/zyla-life-sciences/other-nonoperating-income-expense https://stock.noler.com/us/stock/zyla-life-sciences/other-receivables-net-current https://stock.noler.com/us/stock/zyla-life-sciences/other-restructuring-costs https://stock.noler.com/us/stock/zyla-life-sciences/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/zyla-life-sciences/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/zyla-life-sciences/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/zyla-life-sciences/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/zyla-life-sciences/paid-in-kind-interest https://stock.noler.com/us/stock/zyla-life-sciences/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/zyla-life-sciences/payments-for-deposits https://stock.noler.com/us/stock/zyla-life-sciences/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/zyla-life-sciences/payments-for-restructuring https://stock.noler.com/us/stock/zyla-life-sciences/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/zyla-life-sciences/payments-of-financing-costs https://stock.noler.com/us/stock/zyla-life-sciences/payments-to-acquire-investments https://stock.noler.com/us/stock/zyla-life-sciences/preferred-shares-facts https://stock.noler.com/us/stock/zyla-life-sciences/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zyla-life-sciences/preferred-stock-shares-authorized https://stock.noler.com/us/stock/zyla-life-sciences/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/zyla-life-sciences/prepaid-expense-current https://stock.noler.com/us/stock/zyla-life-sciences/pretax-income https://stock.noler.com/us/stock/zyla-life-sciences/pretax-income-domestic https://stock.noler.com/us/stock/zyla-life-sciences/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-convertible-debt https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-stock-issued https://stock.noler.com/us/stock/zyla-life-sciences/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/zyla-life-sciences/professional-fees https://stock.noler.com/us/stock/zyla-life-sciences/profit-loss https://stock.noler.com/us/stock/zyla-life-sciences/property-plant-equipment https://stock.noler.com/us/stock/zyla-life-sciences/public-float https://stock.noler.com/us/stock/zyla-life-sciences/reorganization-items https://stock.noler.com/us/stock/zyla-life-sciences/reorganization-value-present-value-of-discounted-cash-flows-of-emerging-entity https://stock.noler.com/us/stock/zyla-life-sciences/research-and-development https://stock.noler.com/us/stock/zyla-life-sciences/restricted-cash-noncurrent https://stock.noler.com/us/stock/zyla-life-sciences/restructuring-charges https://stock.noler.com/us/stock/zyla-life-sciences/restructuring-reserve-current https://stock.noler.com/us/stock/zyla-life-sciences/retained-earnings https://stock.noler.com/us/stock/zyla-life-sciences/revenue https://stock.noler.com/us/stock/zyla-life-sciences/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/zyla-life-sciences/revenue-from-related-parties https://stock.noler.com/us/stock/zyla-life-sciences/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/zyla-life-sciences/sales-revenue-goods-net https://stock.noler.com/us/stock/zyla-life-sciences/selling-and-marketing-expense https://stock.noler.com/us/stock/zyla-life-sciences/severance-costs https://stock.noler.com/us/stock/zyla-life-sciences/shareholders-equity https://stock.noler.com/us/stock/zyla-life-sciences/shares-authorized https://stock.noler.com/us/stock/zyla-life-sciences/shares-issued https://stock.noler.com/us/stock/zyla-life-sciences/shares-issued-shares-new-issues https://stock.noler.com/us/stock/zyla-life-sciences/shares-issued-value-other https://stock.noler.com/us/stock/zyla-life-sciences/shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/zyla-life-sciences/short-term-debt https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/zyla-life-sciences/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/zyla-life-sciences/stock-based-compensation https://stock.noler.com/us/stock/zyla-life-sciences/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/zyla-life-sciences/stock-issued-new-shares-sold https://stock.noler.com/us/stock/zyla-life-sciences/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/zyla-life-sciences/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/zyla-life-sciences/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/zyla-life-sciences/stock-options-expirations-in-period https://stock.noler.com/us/stock/zyla-life-sciences/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/zyla-life-sciences/stock-options-outstanding-number https://stock.noler.com/us/stock/zyla-life-sciences/stock-split-ratio https://stock.noler.com/us/stock/zyla-life-sciences/tangible-asset-impairment-charges https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/zyla-life-sciences/tax-rate-reconciliation-tax-cuts-and-jobs-act-percent https://stock.noler.com/us/stock/zyla-life-sciences/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/zyla-life-sciences/total-assets https://stock.noler.com/us/stock/zyla-life-sciences/total-liabilities https://stock.noler.com/us/stock/zyla-life-sciences/total-liabilities-and-equity https://stock.noler.com/us/stock/zyla-life-sciences/total-long-term-debt https://stock.noler.com/us/stock/zyla-life-sciences/unrecognized-tax-benefits https://stock.noler.com/us/stock/zyla-life-sciences/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/zyla-life-sciences/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/zyla-life-sciences/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/zyla-life-sciences/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/zyla-life-sciences/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/zyla-life-sciences/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/zyla-life-sciences/valuation-allowances-and-reserves-adjustments https://stock.noler.com/us/stock/zyla-life-sciences/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/zyla-life-sciences/valuation-allowances-and-reserves-charged-to-cost-and-expense https://stock.noler.com/us/stock/zyla-life-sciences/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/zyla-life-sciences/valuation-allowances-and-reserves-reserves-of-businesses-acquired https://stock.noler.com/us/stock/zyla-life-sciences/warrants-and-rights-outstanding https://stock.noler.com/us/stock/zyla-life-sciences/weighted-average-number-of-share-outstanding-basic-and-diluted